arrow
P

Pietro Merli

bambino gesu children's hospital
H指数:39
被引数:5,199

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tisagenlecleucel for post-transplant relapse in young acute lymphoblastic leukemia patients: European real-world determinants of outcome
Leukemia
IF13.4
2026-08-310
OA
A specific stem cell program and CD112 immunological axis dysfunctions underpinning monosomy 7-associated myeloid neoplasms

特定的干细胞程序和CD112免疫轴功能障碍是7号单体相关髓系肿瘤的基础

2026-05-110
OAAI
Anti-CD7 fratricide-resistant chimeric antigen receptor (CAR) T-cells for relapsed/refractory acute myeloid leukemia

针对复发/难治性急性髓系白血病的抗CD7 fratricide耐受性嵌合抗原受体(CAR)T细胞

Blood
IF23.1
2026-03-050
PRE
Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases

Anti-CD19 CAR T细胞治疗难治性自身免疫性疾病的儿科患者

2026-02-050
PRE
Interindividual HLA evolutionary divergence in mismatched unrelated donor allo-HCT for malignant hematological disorders

不同个体HLA在错配无关供者allo-HCT治疗恶性血液病中的进化分歧

2026-01-010
OA
Fecal microbiota transplantation for decolonization from multidrug-resistant bacteria in pediatric allogeneic hematopoietic stem cell transplantation recipients: a retrospective real-world data study

粪菌移植用于清除儿童异基因造血干细胞移植受者体内多重耐药菌的定植:一项回顾性真实世界数据研究

2025-12-010
OAAI
Performance of treatment response assessment at day 7 by baseline acute graft-vs-host disease severity

基于基线急性移植物抗宿主病严重程度的第7天治疗反应评估表现

2025-09-250
PRE
Sensitivity of Pediatric Myelodysplastic Syndromes With Excess of Blasts With UBTF–TD to Venetoclax/Azacitidine

伴原始细胞增多和UBTF–TD的儿童骨髓增生异常综合征对Venetoclax/Azacitidine的敏感性

2025-09-040
PREAI
GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trial

GD2靶向CAR T细胞在高风险神经母细胞瘤中的应用:一项I/II期临床试验。Nat. Med

2025-08-210
PRE
The MAGIC Composite Response: A Novel Endpoint Integrating Clinical and Biomarker Parameters for Acute GVHD

MAGIC复合应答:一种整合临床和生物标志物参数的急性GVHD新型终点指标

2025-08-190
OAAI
Point-of-care fresh CAR T cells for pediatric or young adult BCP-ALL that is relapsed/refractory or in very-high-risk first relapse

用于儿科或年轻成人复发性/难治性或极高危首次复发的BCP-ALL的床旁新鲜CAR T细胞

2025-06-260
OAAI
The First Case of the Identification of a Microorganism Directly from Whole Blood Using MALDI-TOF Mass Spectrometry in an Onco-Hematological Pediatric Patient with Bloodstream Infection
2025-02-040
OA
Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk Group

移植物抗宿主病治疗期间的系列临床和生物标志物监测确定了不同的风险阶层,包括超低风险组

2025-01-010
PRE
Differences in Acute Graft-Versus-Host Disease (GVHD) Severity and Its Outcomes Between Black and White Patients

黑人和白人患者急性移植物抗宿主病 (GVHD) 严重程度及其结局的差异

2024-11-011
PRE
Outcomes of children and young adults with B-cell acute lymphoblastic leukemia given blinatumomab as last consolidation treatment before allogeneic hematopoietic stem cell transplantation

blinatumomab作为异基因造血干细胞移植前最后巩固治疗的儿童和青年b细胞急性淋巴细胞白血病的结果

2024-10-312
OAAI